drugset / Trial / NCT00956098
Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study investigated the effectiveness and safety of oltipraz therapy in treating patients with cirrhosis induced by chronic hepatitis type B or C.
Timeline
- Start
- 2006-02
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oltipraz | Small molecule | 60 mg | — |
| Subject | Oltipraz | Small molecule | 90 mg | — |